Literature DB >> 6806270

A proenzyme form of human urokinase.

T C Wun, L Ossowski, E Reich.   

Abstract

A culture of the human epidermoid carcinoma HEp 3 produces a plasminogen activator of Mr = 53,000 which we have purified to apparent homogeneity from serum-free conditioned medium by the combination of immunoaffinity chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The highly purified protein has the following properties: 1) It is indistinguishable from urinary urokinase in electrophoretic mobility, in immunodiffusion, and in autoradiographically visualized tryptic peptide maps obtained from the 125I-labeled proteins. 2) The HEp 3 protein differs from urinary urokinase in the following respects: (a) although the apparent molecular weights of the two are identical (Mr = 53,000), the urinary enzyme consists of two polypeptide chains, whereas the HEp 3 protein is a single chain form. (b) Urinary urokinase can be labeled easily by incubation with radioactive diisopropylfluorophosphate but the HEp 3 protein cannot. (c) When assayed by the hydrolysis of a synthetic chromogenic peptide substrate, the HEp 3 enzyme has less than 1% of the catalytic activity of urinary urokinase. 3) On controlled exposure to plasmin, the HEp 3 protein is converted to an active enzyme that is identical with urinary urokinase in molecular weight, polypeptide chain composition, diisopropylfluorophosphate labeling, and specific catalytic activity. We conclude that the HEp 3 protein is a proenzyme that can be converted to active two-chain urokinase by plasmin, probably by a single proteolytic nick in the polypeptide chain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806270

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

Authors:  D R Senger
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

2.  Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.

Authors:  M P Stoppelli; A Corti; A Soffientini; G Cassani; F Blasi; R K Assoian
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.

Authors:  P H Quax; N Pedersen; M T Masucci; E J Weening-Verhoeff; K Danø; J H Verheijen; F Blasi
Journal:  Cell Regul       Date:  1991-10

4.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase.

Authors:  S Namiranian; Y Naito; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

6.  Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases.

Authors:  M H Wang; A Skeel; E J Leonard
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

7.  Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.

Authors:  M Sudol; E Reich
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

8.  Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.

Authors:  M B Berkenpas; J P Quigley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin.

Authors:  L Ossowski; D Belin
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.